Quantum Capital Management (California)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$22K Buy
373
+17
+5% +$1.02K 0.02% 195
2020
Q2
$21K Sell
356
-36
-9% -$2.15K 0.01% 266
2020
Q1
$22K Sell
392
-136
-26% -$8.31K 0.01% 259
2019
Q4
$34K Sell
528
-306
-37% -$17.5K 0.02% 263
2019
Q3
$42K Buy
+834
New +$39.2K 0.02% 271
2014
Q1
Sell
-1,433
Closed -$76K 179
2013
Q4
$76K Hold
1,433
0.01% 182
2013
Q3
$66K Buy
+1,433
New +$62.9K 0.01% 177

Other funds holding BMY

Quantum Capital Management (California)'s BMY Position: Q3 2020 in Review

Quantum Capital Management (California) increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q3 2020, buying an estimated $1.02K and bringing the position to 373 shares worth $22K. The position accounts for 0.02% of the portfolio, ranked #195.

Quantum Capital Management (California) first reported a position in BMY in Q3 2013 and has held it in 7 quarters since. The position peaked at $76K in Q4 2013. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Quantum Capital Management (California) held 373 shares of Bristol-Myers Squibb worth $22K as of Q3 2020.
  • Quantum Capital Management (California) bought 17 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.02K.
  • Bristol-Myers Squibb made up 0.02% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #195 holding.
  • Quantum Capital Management (California) first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 7 quarters since.
  • Quantum Capital Management (California)'s Bristol-Myers Squibb position peaked at $76K in Q4 2013.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.